ROSEN, A LEADING NATIONAL FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Outset Medical, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on October 28, 2024 [1]. Group 1: Class Action Details - Investors who purchased Outset Medical securities between August 1, 2022, and August 7, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6]. - The lead plaintiff must file a motion with the Court by October 28, 2024, to represent other class members in the litigation [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Outset Medical made false or misleading statements regarding its Tablo products, including marketing for unapproved uses and lacking the necessary sales infrastructure [5]. - The claims suggest that these misrepresentations led to adverse impacts on Outset Medical's revenue growth and misled investors about the company's business prospects [5].